GlaxoSmithKline ... some big sales predictions for products like its respiratory syncytial virus (RSV) vaccine and new blood cancer drug Blenrep. By 2031, the UK drugmaker expects sales to top ...

Prevalence rates of what GSK calls "deviant" sexual behaviours caused by the drugs are unknown and tend to be under-reported ...

Full Year 2024 Results Key Financial Results Revenue: UK£31.4b (up 3.5% from FY 2023). Net ...

February 12, 2024 GSK India arm's Q3 profit falls on government price cap GlaxoSmithKline Pharmaceuticals , the Indian unit of the UK's GSK , reported ... to manufacture products for the U.S ...

UK drugmaker GSK is struggling to convince the market ... said investors were confident about the company’s ability to commercialise products, but saw its research and development as more ...